61 year old man was diagnosed with Hodgkin Lymphoma. He then developed COVID. Only got supportive care. No steroids or immunotherapy. 4 months later, cancer had mostly resolved (left image vs right) 🪢
1) Hodgkin Lymphoma is unique among cancers in that what you see as big lumps of tumor are not cancer cells: Bulk of tumor mass is just normal reactive lymphocytes with small amounts of cancer (Reed Sternberg) cells mixed in. (Owl like cells)
So after COVID the reactive cells may disappear due to the severe viral infection, making it look like the cancer has gone into remission. But maybe only the normal reactive cells have disappeared. Time will tell if the true Hodgkin cancer cells are still there and will come back
2) The second explanation is Hodgkin lymphoma is sometimes a difficult diagnosis and we always worry if the initial diagnosis was right. I'm sure the authors have checked this and excluded this possibility.
3) The third explanation is that it is possible that COVID truly triggered an antibody or T cell response that targeted the Hodgkins cancer cells and killed them.
This will be similar to (but in a good way)COVID targeting PF4 or platelets & causing clots or bleeding. Fascinating
Most cases of Hodgkin lymphoma are not associated with EBV. This patient had prior renal transplantation but was not on immunosuppressive treatments. The COVID triggered immune response may have also targeted EBV (specific or non specific) rather than Hodgkins directly.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Breaking: FDA asks states to pause J & J vaccine due to blood clots in 6 women age 18 to 48.
J & J vaccine is an adenoviral vector vaccine, as is the Astra Zeneca vaccine
These unusual clots have NOT been seen with mRNA (Pfizer, Moderna) vaccines. cnbc.com/2021/04/13/us-…
I don't have the details of the 6 cases of thrombosis that prompted the recommendation. But it looks like the concern is the unusual combination of serious blood clots with low platelets in young people that prompted it. Not regular blood clots. @nytimesgoogle.com/amp/s/www.nyti…
The good news is that the US will maintain and reach vaccine related goals even without the J &J vaccine. @ASlavitt is quoted in this story @CNN.
Rare form of blood clots plus low platelets. ~60% involve veins of brain. Almost all after 1st dose.
Risk (UK MHRA): 1 in 250,000 people
Risk (EU EMA): 1 in 100,000 people
Risk of dying: 20-25% of people with these clots have died
Approximately half of the deaths in the UK (11 of 19) were under age 50.
The benefits of the Astra Zeneca vaccine according to regulators appear to outweigh risks in all except those less than age 30. bmj.com/content/373/bm…
While blood clots occur at a certain rate in population what is unusual about these clots is the association with low platelets. Platelets help make blood clots & when platelets are low we are at risk of bleeding not clotting.
Low platelets in context of blood clots is unusual.
Forget who did what wrong on the messaging. Just focus on the messages going forward.
Don't get stuck in debates of whether vaccines prevent transmission. They do reduce transmission dramatically. (It's will also be a largely moot question once 80% have been vaccinated).
Mortality rate of symptomatic COVID when healthcare system was overwhelmed early on (as in Italy, Spain, Belgium, & parts of the US) was incredibly high. As we flattened the curve & learnt to treat, the rate reduced to 2-3%.
It is indeed remarkable how across the world the mortality rate of confirmed, presumably symptomatic, COVID has coalesced to around 2-3%.
Although with improvements in treatment, mortality rates of symptomatic COVID may be lower that what we saw early last year in places that got overwhelmed, no country should be in a situation where the healthcare system is overwhelmed. That leads to much higher loss of life.
IFR can vary: by population characteristics, time period, availability of treatments, health system capabilities, etc.
But the death rate in the US, 1700 deaths per million, shows how devastating COVID can be in a rich country with supposedly the best healthcare resources of any